Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Sep 1;18(9):e315-22.

Medicare Part D and potentially inappropriate medication use in the elderly

Affiliations
Comparative Study

Medicare Part D and potentially inappropriate medication use in the elderly

Julie M Donohue et al. Am J Manag Care. .

Abstract

Objectives: Inappropriate medication use, which is common in older adults, may be responsive to out-of-pocket costs. We examined the impact of Medicare Part D on inappropriate medication use among Medicare beneficiaries.

Study design: Pre-post with comparison group.

Methods: Using data from 34,679 elderly beneficiaries in Medicare plans from 2004 to 2007, we used Healthcare Effectiveness Data and Information Set measures of prescribing quality: (1) any use of Drugs to Avoid in the Elderly (DAE), (2) a proportion of total medication use attributable to DAEs, and (3) any Potentially Harmful Drug-Disease Interactions in the Elderly (DDE). Rates of inappropriate use among 3 groups transitioning from no drug coverage or limited coverage ($150 or $350 quarterly caps) to Part D in 2006 were compared with those with constant drug coverage.

Results: DAE use increased slightly among those moving from no coverage to Part D (from 15.72%-17.61%) whereas the comparison group's use decreased (20.97%-18.32%) [relative odds ratio (ROR) = 1.34, 95% confidence interval [CI] 1.22-1.48, P <.0001]. However, the proportion of total drug use attributable to DAEs declined among the no coverage group after Part D (3.01%-1.98%), a significant difference relative to the comparison group (ROR = 0.84, 95% CI 0.72-0.98, P = .03). Rates of DDE were low (1%) both before and after Part D.

Conclusions: While use of high-risk drugs increased slightly among those gaining Part D drug coverage, high-risk drug use actually declined as a proportion of total drug use, and the prevalence of drug-disease interactions remained stable.

PubMed Disclaimer

References

    1. Pugh MJV, Hanlon JT, Zeber JE, et al. Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm. 2006;12:537–545. - PMC - PubMed
    1. Pugh MV, Starner C, Berlowitz D, Hanlon J. Drug-disease interactions: assessment by disease state. J Am Geriatr Soc. 2010;58:S148. - PMC - PubMed
    1. Lindblad CI, Hanlon JT, Gross CR, et al. Clinically serious drug disease interactions in the elderly: opinion of a consensus panel. Clin Ther. 2006;28:1133–1143. - PubMed
    1. Stockl KM, Le L, Zhang S, Harada AS. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Managed Care. 2010;16(1):e1–e10. - PubMed
    1. Kaiser Family Foundation . Fact Sheet: The Medicare Prescription Drug Benefit. Washington DC: 2008.

Publication types